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Summary
Murine monoclonal antibodies (mAbs) M38 and L31 define two epitopes of a surface protein
of activated lymphocytes and monocytes. It has been shown that M38 also defines a crossreactive
epitope of human immunodeficiency virus type 1 (HIV1) gp120 (Beretta et al., 1987. Eur. J.
Immunol. 17:1793). The mAb inhibits syncytia formation driven by HIV-1-infected cells. The
surface protein was demonstrated to be a class I MHC ot chain, by sequence analysis of the
corresponding cDNA and by immunological means. The epitopes defined by mAbs M38 and
L31 are monomorphic and hidden (i.e., inaccessible to antibodies) on native HLA molecules
expressed by resting cells, but can be evidenced on denatured proteins by Western blot analysis.
The two epitopes become accessible afteractivationprocesses havebeen implemented, likely reflecting
a conformational alteration of at chains (such as that described by Schnabl et al. 1990. J Exp.
Med. 171:1431) . Consistent with molecular data are the results offunctional analysis, which indicate
that the molecule recognized by M38 and L31 is a gate for pleiotropic negative signals, since
the two mAbs were shown to inhibit monocyte antigen presentation and lymphocyte mitogenic
proliferation, respectively.
H
IV infection of susceptible cells starts with the interac-
tion ofviralgp120 with the CD4 molecule (1-3) . Since
CD4 belongs to the Ig superfamily, whose members are in-
volved in regulatory interactions essential for the immune
system function (4-6), the specificity ofgp120 for this mole-
cule could be central for the virus in evading the host im-
mune response.
Beside the depletion of CD4+ cells due to HIV cytopathic
effects, other gp120-related mechanisms for amplification of
immune damage have been proposed: killing ofbystander cells
induced by soluble gp120 (7, 8), anti-CD4 autoantibodies
induced by CD4-like idiotopes expressed within the env-specific
repertoire (9), synergism between gp120 and anti-gp120 an-
tibodies in blocking T cell activation (10), and blockade of
the differentiation of CD4+CD8+ thymocytes into CD4+
CD8 - T lymphocytes secondary to gp120 binding to CD4
(11, 12).
CD4 is a ligand of class II MHC and interacts with other
proteins in the context of a multimolecular complex (13, 14) .
HIV might have evolved its specificity for CD4 by mimicry
of a physiological ligand of CD4. Experimental evidence of
serological crossreactivity between viralenvelope and human
epitopes have already appeared in two independent reports.
One case is the identification of homologousregions in HIV-1
gp41 and human classII MHC (/3-1 domain). A fraction (36%)
of AIDS patient sera was shown to contain antibodies reacting
with a class II-derived peptide and with native class II an-
tigens (15). Further, a gp120-specific mAb, M38, was shown
to crossreactwith a surface protein of activated humanmono-
cytes endowed with negative signaling potentials (16).
The present work describes by biochemical, immunolog-
ical, and genetical means the crossreactive human surface pro-
tein defined by mAb M38. Such a molecule resulted in being
a class I MHC heavy chain, present on activated immuno-
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resting cells, likely corresponding to the conformational al-
teration of ca chains (not associated with 02m) recently de-
scribedby Schnabl et al. (17) . We present evidence that such
conformationally altered moleculesmightbe involved in func-
tional regulatory mechanisms.
Materials and Methods
Monoclonal Antibodies.
￿
mAbs OKT3, -4, -8, and -9 were pur-
chased from Ortho Diagnostics Systems, Inc., (Raritan, NJ), and
Leu-3a was from Becton Dickinson & Co. (Mountain View, CA).
The antiTAC DMS-1 (18) and the anti-CD3 UCTH-1 (19) were
kindly provided by Drs. SmithandBeverly (ICRF, London), respec-
tively. mAb 01.65 (20), specific for a common determinant of
HLA-A, -B, -C molecules, and mAb R1.30, specific for02m (20),
were kind gifts ofDr. Malavasi (Department of Genetics, Univer-
sity ofTorino, Italy), mAbCR11.351, specific for apolymorphism
determinant of HLAA2 (21), was a kind gift of Dr. Russo (Co-
lumbia University, New York). M38, L31, and D28 were derived
from the same fusion (16); D28 was used as acontrol of irrelevant
specificity.
Cells.
￿
Human PBMC, isolatedby Ficoll-Hypaque discontinuous
gradient centrifugation were cultured afterstimulation with OKT3
and rabbit anti-mouse Ig antibodies (22) or with 5 Aglml Con
Ato obtain activatedlymphocytes. Rexcells, ahuman Tlympho-
blastoid cell line, were a kind gift of Dr. Acuto (Department of
Immunology, Pasteur Institute, Paris). 81351 (LAV) cells, which
harbor a single integrated copy of apot mutant of HIV-1 (LAV)
and produce defective, uninfectious virions (23), were a kind gift
ofDr. Folks (Center for Disease Control, Atlanta, GA). MOLT3
cells were akind gift ofDr. De Rossi (OncologyInstitute, Univer-
sity of Padova, Italy.
Cytofuorimetry.
￿
Lymphocytes of8E51(LAV)cells were washed
and resuspended in RPMI 1640 containing 20% normal human
serum. Cells (106 cells/200Al) were incubated on ice for 30 min
with the appropriate dilution ofmAb.Aftertwowashings in RPMI
1640, FITC-conjugated rabbit anti-mouse Igs(Dakopatts a/sGlos-
trup, Denmark) were added and cells were incubated 30 min on
ice. Washed cells were fixed in 5% paraformaldehyde and applied
to aSpectrum III flow cytometer(Ortho Diagnostics Systems, Inc.).
Fortheblocking experiment to demonstrate that M38 couldbind
both the viral and thecellular antigens, Con A-activated lympho-
cytes were used: 1 legof M38 (or01.65) waspreincubated (30min
at room temperature) with an eightfold molar excess (5 Fcg) of
recombinant soluble gp160(Transgene, Strasbourg). A FACScana
(Becton Dickinson & Co.) was used for this experiment.
Radiolabelled mAbCell Binding Assay.
￿
mAbs were purified from
ascitic fluids by (NH4)2SO4 precipitation and protein A-Sepharose
(Pharmacia Fine Chemicals, Piscataway, NJ)affinity adsorption and
radioiodinated using Enzymobeads (Bio-Rad Laboratories, Rich-
mond, CA) and Na '251 (Amersham Corp., Arlington Heights,
IL). For the cell binding assay, cells were resuspended at 5 x
106/mlin RPMI 1640 supplemented by 5% rabbit serum; 100 Al
of the cell suspension was loaded onto a two-step gradient in 0.3-
ml tubes (lower layer: 90% FCS and 10% sucrose; upper layer:
80% silicon oil and 20% mineral oil) with appropriate dilutions
of radiolabeled mAbs andcompetitors. After a 30-min incubation
at 37°C, cell-bound and free radioactivity was determined after
centrifugal cell separation.
Radioiodination, Immunoprecipitation, andSDS/PAGE.
￿
Cells were
radioiodinated by thelactoperoxidase method andlysed in digitonin
lysis buffer (10 mM Tris-HCI, pH 7.5; 5mM EDTA;0.15M NaCl;
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2% digitonin; 10 MM NaF; 1 mM PMSF; 10 mM iodoacetamide;
5 hg/ml leupeptin, and pepstatin A). The lysates were adsorbed
on mAb-Affigel beads(Bio-Rad Laboratories) for1 h at 4°C. After
four washes in Digitonin lysisbuffer, thematerial was eluted from
the beads with SDS/PAGE sample buffer (with or without 2%
02m). SDS/PAGE was run using vertical slab gels and 10%
acrylamide.
Immunoabsorption Assay.
￿
Activated lymphocytes (3 x 10'/ml)
were suspended in Triton lysis buffer (20 mM Tris-HCI, pH 7.4;
0.15 M NaCl; 10 mM NaF; 2.5 mM EDTA; 1% Triton X-100;
10 mM iodoacetamide; 1 mM PMSF; 5 hg/ml leupeptin) at 4°C
for30 min.Postnuclear supernatants were loaded on affinity columns
of Affigel (BioRad Laboratories) coupled to the indicated mAbs
(3 mg/ml of packed beads). The first 3 ml effluent and the SDS-
eluted material were acetone precipitated and resuspended in
SDS/PAGE sample buffer forWestern Blot analysis with "5I-M38
and "'I-L31.
Syncytia Formation Assay.
￿
81351 (LAV) cells and MOLT3 cells
were grownin RPMI 1640 supplemented by 10% FCS to concen-
trations of 106cells/ml, washed in medium, mixed in 1:2 propor-
tions, and distributed in V-shaped microtiter wells (1.6 x 105
cells/well) with theaddition of mAbs or ofantisera in appropriate
dilutions. After a 30-min incubation at 37°C, the cells were
sedimented by centrifugation and incubated as a pellet for 3 h at
37°C. Syncytia of dimensions of 10 to >100 cells were scored with
an inverted microscope after transfer of the resuspended pellet to
flat-bottomed well microtiter plates. In uninhibited control samples,
100-150 large Syncytia/well were counted.
Immunoselection of Recombinant Phages
￿
"5I-M38 and -L31.
Recombinant phage plaques (2 x 106) of Agtll cDNA expres-
sion libraryfrom human PHA-stimulated Tlymphocytes (HL1031b;
Clontech Laboratories Inc., Palo Alto, CA) were screened according
to Young andDavis (24) with minor modifications: dry milk was
used to overcoat the filters, and directly labeled antibody (106
cpm/ml of either 1251-L31 or '2'I-M38, both at a specific activity
of 41 mCi/mg) was used instead of cold antibody and
'251-
Staphylococcus Protein A.
Subdoning and Sequencing of cDNA.
￿
A phage clone, positive
with 1251-L31 and 1251-M38 and negative with an irrelevant anti-
body, was chosen for further analysis. The insert was subdoned
into the EcoRI site of the plasmid vector pUC8, and the recom-
binant plasmid (PL208) was sequenced according to the method
of Sanger et al. (25). A Data Bank search was done with theFASTN
algorithm to compare the DNA sequence with the EMBL data
bank.
Lymphocyte Proliferation Assays.
￿
Tetanustoxoid presentation ex-
periments were performed as described (16); adherent monocytes
(2 x 104/assay) were pulsed with tetanus toxoid (20 ng/assay), an-
tibodies were used as 1:100 ascites and purified T cell (105/assay)
proliferation was evaluated at day 5 by ['H]thymidine incorpo-
ration.
Mitogenic proliferation of PBMC (2 x 105/assay) stimulated
by crosslinked OKT3 or by other mitogens was evaluated by
['H]thymidine incorporation at day 4. Antibodies were used as
1:200 ascites and added to the culture twice, at day 0 and at day
2. 11,2 production by human PBMC cultured for 18 h afterstimu-
lation by crosslinked OKT3 was evaluated as described by Gillis
et al. (26) .
Results
Characterization ofmAbL31.
￿
mAb L31 was derived from
the same HIV-immunized mouse that yielded M38 (16). ItFigure 1 .
￿
Reactivity pattern ofmAbs M38 and L31 . (A) Western blot
of radioiodinated M38 (M and L31 (L) on HIV-1, HIV-2, and HTLV-1
commercial strips (Sorin Biomedica and BioRad Laboratories) . The refer-
ence AIDS serum (S) was revealed by 1251-Protein A . (B) SDS-PAGE of
the materials immunoprecipitated by M38 (M, L31 (L), and UCTH-1
(L0 from lysates of OKT3-stimulated lymphocytes, surface labeled by 1251
(lactoperoxidase method) .
was selected for its strong reactivity in commercial HIVELISA
and wasshown to bind the surface of activated humanPBMC
by cell binding assays and by flow cytometry . Since these prop-
erties were similar to those described for M38, we compared
the specificities of the two antibodies in Western blot and
radioimmunoprecipitation assays.
The reactivity pattern of 1251-L31 and -M38 on HIV-1,
HIV-2, and HTLV1 Western blot strips (Fig . 1 A) proved
to be similar, even though not identical: both antibodies reacted
with a 45-kD protein band, while onlyM38 recognized the
env product of HIV-1 (but not that of the other two
retroviruses) . Radioimmunoprecipitations of lysates from
surface-labeled activated lymphocytes demonstrated that both
L31 and M38 precipitate similar (likely identical) 45-kD bands
and fainter 90-kD bands (Fig . 1 B) .
The number of antibody binding sites on the lymphocyte
surface was found to increase 10-40-fold after polyclonal lym-
phocyte stimulation by OKT3 (Fig. 2 A) . The affinity of
the interaction (Kd = 5 nM) was deducted by Scatchard plot
analysis of equilibrium binding assays. The L31-defined an-
tigen, undetectable at day 0 by flow cytometry analysis, was
detected on the majority of cells at day 3 (Fig . 2 B) . Con-
versely, Western blot analysis ofwhole cell lysates with L31
(Fig. 2 B) demonstrated quantitatively similar reactivities in
resting and activated lymphocytes. Analogous results were
obtained withM38 (data not shown) . These results indicate
that the protein is present in a fashion inaccessible to anti-
bodies in resting cells . The epitopes recognized by the two
mAbs become accessible on the cell surface only as a conse-
quence of mitogenic activation .
M38 andL31 React with the Same CellProtein.
￿
To confirm
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Figure 2 .
￿
Differential reactivity ofmAb L31 on live cells and on dena-
tured proteins. (A) Binding of L31 to a cell surface antigen of activated
lymphocytes. PBMC were cultured after stimulation with OKT3 and rabbit
anti-mouse Ig antibodies. The number of 1251-L31 binding sites was de-
termined by Scatchardplot analysis after subtraction ofnonsaturable binding,
as detected in the presence of 100-fold molar excess of unlabeled L31 . (B)
L31-cytofluorimetry and Western blots on whole cell lymphocyte lysates
at day 0 and at day 3 after OKT3 stimulation.
the hypothesis that M38 and L31 recognize two epitopes of
the same cell protein, lysates from activated lymphocytes were
adsorbed onto four immunoaffinity columns bearing L31,
M38, and two control irrelevant isotype-matched mAbs,
respectively. Either effluents or SDS-released eluates were ana-
lyzed by immunoblotting with 1251-M38 (Fig . 3 A) or
1251-
L31 (Fig . 3 B) . The L31 column (but not those bearing con-
trol antibodies) caused a major immunodepletion in the
effluent (Fig . 3, lanes a) and an almost quantitative recovery
of the 45-kD band in the eluate (lanes b) . The protein band
was decorated equally well by either antibody. Similar results
were obtained with the M38 column, although this antibody
was less efficient than L31 in retaining the 45-kD protein .
These results indicate that the cell protein defined by M38
is identical to that recognized by L31 .
Fine Specificity ofM38 and L31 .
￿
The interaction ofM38
with the cellular antigen on the surface of activated lympho-
cytes (measured by flow cytometry) could be significantly re-
duced by soluble recombinant gp160; in the same conditions,
the binding ofmAb 01.65 (20), specific for acommon deter-
minant ofHLA-A, -B, -C molecules was unaffected (Fig. 4) .
Also unaffected was the binding of L31 (data not shown) .
To further analyze the specificities ofM38 and L31 with
respect to HIV1, the two antibodies were used in gp120-
related assays on living cells . 8E51(LAV) cells and MOLTS
cells, sedimented together in Vshaped wells and incubated
as a pellet, form large syncytia . The assay can be inhibited
by anti-CD4mAbs and by patients sera containing neutralizing
antibodies . The addition ofmAb M38 resulted in a marked
inhibitory effect (Fig. 5 A), while L31 and a number ofmAbs
(specific for HIV antigens or of irrelevant specificity) had no
effect at all . These data, together with the cytofluorimetry
findings on 8E51(LAV) cells, labeled by M38 and by other
anti-gp120 mAbs, while not by L31 (Fig. 5 B), confirm the
differential anti-gp120 specificity of M38 .Immunoselection ofRecombinant Phages and Sequence Anal-
ysis of the cDNA of the Cellular Protein Defined by M38 and
L31 . To identify the cell protein defined by the two anti-
bodies, 125I-L31 was used to screen a commercial XGT11
cDNA expression library from PHA-activated human PBL .
Positive plaques were counter-screened with "'l-M38 and
with an irrelevant radioiodinatedmAb. A clone, reactive with
both L31 and M38 and showing no binding with the isotype-
matched control antibody, was selected . The reactivity ofphage
101 10 2
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Figure 4 .
￿
Demonstration that the binding ofmAb M38 (but not that
ofmAb 01.65) to cells can be competed by gp160 . Indirect cytofluorim-
etry of activated lymphocytes with mAbs M38 or 01.65 in the presence
(dotted lines) and in the absence (solid lines) of soluble recombinant gp160 .
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Figure 3 .
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Demonstration that mAbs
M38 and L31 recognize the same cel-
lular protein . Activated lymphocyte ly-
sates were loaded onto affinity columns
of Afgel coupled with the indicated
mAbs . The effluent andthe SDS-eluted
material were acetone precipitated for
Western Blot analysis with 1251-M38
(A) and 1251-L31 (B). Lanes a and b
were loaded with effluent and eluate,
respectively.
recombinant a-galactosidase was confirmed by Western blot
analysis of IPTG-induced phage lysates (data not shown) .
The insert (1,549 bp) was subcloned into the vector pUC8,
and the recombinant plasmid (PL208) was then sequenced .
The insert sequence contained an open reading frame (be-
tween nucleotide residues 10 and 1108) (Fig. 6) coding for
a protein of 366 aminoacids. A data bank comparison of the
nucleotide sequence revealed a high degree of homology with
the class I MHC gene family. The sequence is not identical
to any of the already sequenced alleles, while maximal ho-
mology was found with the alleles of the C locus.
A direct comparison to all the available C alleles amino
acid sequences (27, 28) is seen in Fig. 7 . A 96% homology
was found with allele Cb-1 . The protein contains the charac-
teristic six domains of class IMHC heavy chains (leader pep-
tide, ci 1, a 2, (x 3, transmembrane, and cytoplasmic do-
mains) and the three C-specific residues (val-52, glu-183, and
glu-268) . The five cysteine residues and the glycosylation site
(gin-87) are conserved . Moreover, all but two variations from
the consensus are in residues that show the same amino acid
substitution in at least one other sequenced C allele ; the two
variations unique to this sequence are trp-14 and glu-49 . These
data strongly suggest that the sequenced polypeptide is a
product of an allele of the HLA-C locus.
M38 and L31 Recognize "Hidden"Epitopes ofClass IMHC
a Chains. An immunological approach to confirm that the
protein defined by M38 and L31 is a class IMHC heavy chain
was based upon immunoprecipitations from detergent lysates
of Rex cells (reactive with both M38 and L31) using either
mAb 01.65 (20), specific for acommon determinant ofHLAA,
-B, -C molecules, or mAb R1.30, specific for 02m (20) .
QmAb OKT4 was included as a control. Both precipitates and
supernatants were analyzed by immunoblotting with t251-
L31 . As can be seen in Fig . 8, both antibodies precipitated100
0
79 a 50
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L31-reactive material. However, mAb 01.65 precipitated most
of the material, while only a fraction was bound by mAb
R1.30. The control experiments with mAb OKT4 displayed
all the L31-reactive material confined to the supernatant.
M38 and L31 did react with the activated lymphocytes of
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Figure 5. Differential activity of
mAbs M38 and L31 in gp120-related
assays. (A) Inhibition of syncytia for-
mation between 8E51(LAV) and
MOLTS cells by M38 and lack of effect
by L31. (B) Indirect cytofluorimetryof
8E51(LAV) cells with the two mAbs.
20 unrelated HLAtyped individuals. Further, SDS-denatured
molecules immunoprecipitated from resting lymphocyte ly-
satesby mAb CR11.351(21), specific for HLAA2molecules,
displayed similar reactivity when challenged with the two
antibodies. As a consequence of these findings, the two epi-
0001
￿
I Signal peptide -->
￿
I Alpha-1 -->
GAATTCGGGGGGGAGAMCGGGTCATGGCGCCCCGAACCCTCATCCTGCTGCTCTCGGGAGCCCTGGCCCTGACCGAGACCTGGGCCGGCTCCCACTCCA
0
TGAGGTATTTCTCCACATCCGTGTCCTGGCCCGGCCGCGGGGAGCCCCGCTTCATCGCAGTGGGCTACGTGGACGACACGCAGTTCGTGCGGTTCGACAG
0201
CGACGCCGCGAGTCCAAGAGGGGAGCCGCGGGAGCCGTGGGTGGAGCAGGAGGGGCCGGAGTATTGGGACCGGGAGACACAGAAGTACAAGCGCCAGGCA
0301
￿
I Alpha-2 -->
CAGGCTGACCGAGTGAACCTGCGGAAACTGCGCGGCTACTACAACCAGAGCGAGGACGGGTCTCACACCCTCCAGAGGATGTTTGGCTGCGACCTGGGGC
0401
CGGACGGGCGCCTCCTCCGCGGGTATAACCAGTTCGCCTACGACGGCAAGGATTACATCGCCCTGAACGAGGATCTGCGCTCCTGGACCGCCGCGGACAC
0501
GGCGGCTCAGATCACCCAGCGCAAGTGGGAGGCGGCCCGTGAGGCGGAGCAGCGGAGAGCCTACCTGGAGGGCACGTGCGTGGAGTGGCTCCGCAGATAC
0301
￿
I Alpha-3 -->
CTGGAGAACGGGAAGGAGACGCTGCAGCGCGCGGAACACCCAAAGACACACGTGACCCACCATCCCGTCTCTGACCATGAGGCCACCCTGAGGTGCTGGG
0701
CCCTGGGCTTCTACCCTGCGGAGATCACACTGACCTGGCAGTGGGATGGGGAGGACCAAACTCAGGACACCGAGCTTGTGGAGACCAGGCCAGCAGGAGA
0801
TGGAACCTTCCAGAAGTGGGCAGCTGTGGTGGTGCCTTCTGGAGAAGAGCAGAGATACACGTGCCATGTTCAGCACGAGGGGCTGCCGGAGCCCCTCACC
0901
￿
I Transmembrane region -->
CTGAGATGGAAGCCGTCTTCCCAGCCCACCATCCCCATCGTGGGCATCGTTGCTGGCCTGGCTGTCCTGGCTGTCCTAGCTGTCCTAGGAGCTATGGTGG
1001
￿
I Cytoplasmatic tail -->
CTGTTGTGATGTGTAGGAGGAAGAGCTCAGGTGGAAAAGGAGGGAGCTGCTCTCAGGCTGCGTCCAGCAACAGTGCCCAGGGCTCTGATGAGTCTCTCAT
1101
￿
13' Untranslated sequence -->
CGCTTGTAAAGCC,U$GACAGCTGCCTGTGTGGGACTGAGATGCAGGATTTCTTCACACCTCTCCTTTGTGACTTCAAGAGCCTCTGGCATCTCTTTCTG
1201
CAAAGGCATCTGAATGTGTCTGCGTTCCTGTTAGCATAATGTGAGGAGGTGGAGAGACAGCCCACCCCCGTGTCCACCGTGACCCCTGTCCCCACACTGA
1301
CCTGTGTTCCCTCCCCGATCATCTTTCCTGTTCCAGAGAAGTGGGCTGGATGTCTCCATCTCTGTCTCAACTTCATGGTGCGCTGAGCTGCAACTTCTTA
1401
CTTCCCTAATGAAGTTAAGAACCTGAATATAAATTTGTTTTCTCAAATATTTGCTATGAAGGGTTGATGGATTAATTAAATAAGTCAATTCCTGGAAGTT
1501
GAGAGAGCAAATAAAGACCTGAGAACCTTCCAAAAACCCGCCCGAATTC
Figure 6.
￿
Nucleotide sequence of the insert of a recombinant phage immunoselected by the mAbs. The insert (1,549 bp) was subcloned into the
vector pUC8, and the recombinant plasmid (PL208) was then sequenced. The insert sequence contains an open reading frame (between nucleotide
residues 10 and 1108) coding for a protein of 366 amino acids bearing high homology to HLA-C alleles. the first and last codons of the open reading
frame are underlined. The boundaries of the six domains characteristic of class I MHC heavy chains are indicated' These sequence data are available
from EMBL/Gen-Bank/DDBJ under accession number X58536.Alpha-2 domain
Alpha-3 domain
derived from the individual sequences.
Signal peptide
58
Alpha-1 domain
AU
topes defined by L31 and M38 may be truly classified as mono-
morphic and common determinants of HLA-A, -B, and -C
molecules. Such determinants, inaccessible to the antibodies
on the surface of resting lymphocytes, become available to
antibody reaction only as a consequence of mitogenic activa-
tion. These findings suggest that mitogenic activation in-
duces the expression of classI MHC cx chains in two different
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Figure 7.
￿
Direct comparison of the deduced amino acid sequences of PL208 and of all the available HLA-C alleles. CONS-C is a consensus sequence
conformations. The conformation coprecipitable with 02m
and inaccessible to M38 and L31 is identical to that ofresting
cells, while the second one is not coprecipitable with 02m
and bears the "hidden" epitopes now accessible to antibodies.
The above reported findings (and their interpretation) are
very similar to those of Schnabl et al. (17), who demonstrated
that activated T lymphocytes express classI MHC heavychains
Transmembrane region Cytoplasmatic tail
CONS-C EPSSQPTIPIVGIVAGLAVLAVLAVLGAVVAVVMCRRKSS GGKGGSCSQAA SSNSAQGSDESLIACK
Cb-1
Cb-2 -----------------------------M---------- ----------- ----------------
Cw-1 ----------- ----------------
Cw-2.1 ---------------------------------------- ----------- ----------------
Cw-2.2 ---------------------------------------- ----------- ----------------
Cw-3 ----------- ----------------
Cw-4 ----------M---------V---------TAM------- ----------- C------------T--
Cw-5 G--------------------------------------- ----------- ----------------
CwBL18 ---------------------------------------- ----------- ----------------
Cx52 -----------------------------M---------- ----------- ----------------
PL208 K---------------------------M----------- ----------- ----------------
CONS-C CSHSMRYFYTAVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQTDRVSLRNLRGYYNQSEA
Cb-1 --------S-S-------------------------------------------------------------------------------
Cb-2 ------------------------------------------------------------------------A-----------------
Cw-1 -----K--F-S------------S------------------------------------------------------------------
Cw-2 .1 ---------------S----H---------------------------GR--------------------------N--K----------
Cw-2 .2 ---------------S----H-------------------------------------------------------N--K----------
Cw-3 G-------C-----------H------------------DE------------RK--------------P--------------------
Cw-4 *-------D-------A------S------------------------------------------------A----------------D
Cw-5 --------------------H-------------Q-----------------------------------------N--K----------
CwBL18 --------------------H----------------------------------------__---------A-----------------
Cx52 -------------------ET------------R---------------------A-----------------
PL208 G-------S-S--W----------------------------------E-----------------------A---N--K---------D
CONS-C GSHTLQRMYGCDLGPDGRLLRGYDQSAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQWRAYLEGTCVEWLRRYLENGKETLQRA
Cb-1 ------W-F--------------------------------------------------------R---------------------S----
Cb-2 --------------------------------------------------------------------------------------------
Cw-1 ------W-C----------------Y---------------------------------------R---------------------S----
Cw-2 .1 ------------------------------------------------------------------------E--------------K----
Cw-2 .2 ------------------------------------------------------------------------E-------------------
Cw-3 ---II-------V------------H--------------------N------------------L------L---------K-------G-
Cw-4 --------S----------------------------------------------------A---L------L-------------------
Cw-5 -----------------------N-F---------------------K-----------------R--------------------K-----
CwBL18 --------------------------------------------------------------------------------------------
Cx52 -------------------------V--------------------------------------------------CV---------S----
PL208 --------F--------------N-F---------------------------------------R--------------------------
CONS-C EHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQRWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRW
Cb-1 ------------------------------------y,7----------------------------M--------------------------
Cb-2 --------------------------------------------------------------------------------------------
Cw-1 ------------------------------------W----------------------------M--------------------------
Cw-2 .1 ----------------------------T---------------------------------------------------------------
Cw-2 .2 ----------------------------T---------------------------------------------------------------
Cw-3 ------------------------------------W-------------------------------------------------------
Cw-4 -P-----N---L------------------------------------------------K---------Q-------M-----Q-----S-
CwBL18 -------------------------_------------------------------------------------------------------
Cx52 --------------------------------------------------------------------------------------------
PL208 ------------------------------------W-----------------------K-------------------------------
CONS-C MRVMAPRTLILLLSGALALTETWA
Cb-1
Cb-2 ------------------------
Cw-1 ------------------------
Cw-2 .1 ------------------------
Cw-2 .2 ---------L--------------
Cw-3 ------------------------
PL208Figure 8.
￿
Demonstration that theL31-definedepitope is present on dena-
turedHLA chains. Postnuclear supernatants ofRex cell Triton lysates were
loaded on affinity columns of Affigel coupled with the indicated mAbs.
mAb 01.65 is specific for a common determinant ofHLA-A, -B, -C mole-
cules ; mAb R1.30 is specific for 02m and mAb OKT4 was included as
a control . The precipitate (p) and the supernatant (s) were subjected to
Western Blot analysis with 1251-1,31 .
not associated with 02M . This was inferred on the basis of
the reactivity ofmAb LA45 with SDS-denatured, but not
associated with 02m, heavy chains and with heavy chains ex-
pressed on the surface of activated (but not resting) lym-
phocytes .
The epitopes recognized by M38 and L31 seem to be similar
to that recognized by LA45 ; indeed, neither our antibodies
(Fig . 1 B), nor LA45, coprecipitated ß2m. Conversely, the
anti-ß2m antibody R1.30 immunoprecipitated only a frac-
tion of the L31-reactive material (Fig. 8), in close analogy
with the observationby Schnabl et al. (17) withmAb W6/32,
which immunoprecipitates only ß2m-associated heavy chains.
Functional Consequences of the Interaction ofM38 and L31
with Immunocytes. Schnabl et al . (17) have suggested that
the conformational alteration of class I proteins upon T cell
activation might have some important functional implica-
tions . In light of our previous finding of antigen presenta-
tion inhibited by M38 (16), we investigated the functional
effects elicited by interaction of the two antibodies with im-
munocytes. Indeed, several mAbs reactive with class Imono-
morphic determinants were reported to influence lympho-
cyte proliferation in different experimental models (20, 29-31) .
Antigen presentation was not inhibited by the addition of
L31, at variance with the influence of M38 (Fig . 9 A) . Fur-
ther, L31 inhibited lymphocyte proliferation induced by poly-
clonal mitogenic stimuli . The addition of L31 (but not of
M38) significantly inhibited the mitogenic response ofhuman
lymphocytes challenged with either ConA or anti-CD3 (Fig.
9 B) . Such inhibition was concomitant to a reduction in IL-2
production (Fig . 9 C) . This result is concordant with the
finding that exogenously added IL-2 could reverse the inhibi-
tion of lymphocyte proliferation by L31 (data not shown) .
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￿
Functional consequences of the interaction ofmAbs M38 and
L31 with immunocytes . (A) Inhibition of antigen presentation by M38
and lack of inhibition by L31 and controls. Tetanus toxoid presentation
experiments were performed as described in Materials and Methods . (B)
Inhibition ofmitogenic proliferation by L31 and lack of inhibitionby M38
and controls . PBMC were stimulated by crosslinked OKT3 . [ 3H]Thymi-
dine incorporation was evaluated at day 4. Antibodies were used as 1:200
ascites. (C) IL-2 production by human PBMC, cultured for 18 h after stim-
ulationby crosslinkedOKT3 in the presence ofL31 orOKT9 (as a control) .
The interaction of CD4 to class II MHC and to HIV-1
gp120 has been recently reported as involving different do-
mains of the molecule (12, 32) . However, the finding that
soluble gp120 can inhibit CD4-class IIMHC binding raises
the possibly that the CD4 binding sites for the two ligands
may be overlapping .
To verify the hypothesis that HIV could mimic a physio-
logical ligand ofCD4, we analyzed a panel ofmurine mAbs
raised against HIV-1 looking for crossreactivities between env
products and activated human PBMC. The expectation to
find a crossreactivity with class II MHC molecules was not
fulfilled : instead, we characterizedmAb M38, which defines
an epitope shared by HIV-1 gp120 and by class IMHC heavy
chains . Such a determinant proved to be monomorphic,
common toHLAA, -B, -C molecules and accessible to the
antibody on activated, but not resting, immunocytes .
We had earlier reported that the anti-gp120 specificity of
mAb M38 was shared with an "activation protein" present
on human monocytes (16) . We then provided a tentative defini-
tion of the human target molecule as an "8041) protein",
which was the most prominent band in radioimmunoprecipi-
tation from metabolically labeled cells. The 45-kD minor band
was also present, but was at the time interpreted as a non-
specific signal and overlooked . The findings obtained by sev-
eral analytical approaches confidently demonstrate that the
reactive protein has a molecular mass of 45 kD. The previous
conclusions are likely to be referable to incomplete sample
reduction : dimerization ofHLA molecules in tissue extracts
(33) and molecular masses of 90/45 kD under nonreducing
conditions have been reported for HLA molecules (17) .
Here, we report the results obtained from the analysis of
L31, amAb derived from the same fusion yielding M38 . L31
proved to be specific for the same cell protein recognized
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L31 0by M38 (Fig. 3), even though lacking the crossreactivity with
HIV-1 gp120. The anti-gp120 specificity of M38 was docu-
mented by western blot analysis on SDS-denatured proteins
(Fig. 1) and by assays on live HIVinfected cells (i.e., inhibi-
tion of syncytia formation and cytofluorimetry) (Fig. 5). M38
inhibited syncytia formation between 8E51(LAV) and MOLT3
cells, a CD4-dependent reaction, although it did not inhibit
the infectivity of free virus, as already reported (16) . This
finding confirms that virus penetration and syncytia forma-
tion are distinct, discrete reactions, although with common
steps.
The cellular protein defined by M38 and L31 could be in-
cluded among the products of class I MHC. This was in-
ferred by sequence analysis ofthe cDNA (Figs. 6 and 7) from
a recombinant phage expressing the epitopes recognized by
the two antibodies and by immunoblotting with L31, the
precipitates of mAb 01.65 (anti-HLA-A, -B, -C), of mAb
R1.30 (anti-02m) (Fig. 8), and of mAb CR11.351 (anti-
HLAA2) (20, 21). The two epitopes defined by L31 and M38
could be classified as monomorphic and common determinants
of HLA-A, -B, and -C molecules. These findings explain the
presence of the M38- and 1,31-defined protein in the retrovirus
preparations used for Western blots (Fig. 1); as demonstrated
by Gelderblom et al. (34), HLA proteins are present in
retroviral virions.
The class I molecule recognizedby the two mAbs on the
surface of activated immunocytes could not be assimilated
to conventional HLA molecules, since the corresponding epi-
topes appear to be hidden in HLA molecules present on the
surface of resting immunocytes. A strikingly similar situa-
tion has recently been reported by Schnabl et al. (17). They
demonstrated the reactivity ofmAb LA45 with SDS-denatured
(but not with 02m-associated) a chains and with a chains
expressed on the surface of activated (but not resting) lym-
phocytes. By differential immunoprecipitations and "indepen-
dent capping" experiments, they concluded that activated T
lymphocytes express class I MHC heavy chains not associated
with 02m, together with "conventional" 02m-associated
HLA molecules. Analogous results and conclusions were
reached by Smith and Barber in the mouse system (35) .
The "hidden"epitopes recognized by our mAbs M38 and
L31 seem to be, in all their properties, similar to that recog-
nized by LA45 and, indeed, none of the three antibodies
coprecipitated 02m. Immunohistochemistry analysis of M38
and L31 reactivityindicates that the tissue distribution is com-
pletely different from that of mAbs specific for monomorphic
HLA-A, HLA-B, or for determinants common to HLA-A,
-B, -C products (P G. Natali, personal communication).
Schnabl et al. (17) hypothesize that the loss of 02m and
the conformational alteration ofclass I MHC proteins upon
T cell activation might have some important functional im-
plications. Indeed, this issue has been already addressed in
our previous work, where we showed that M38 inhibited
antigen presentation (16). We have now expanded that ini-
tial observation by studying the functional consequence of
the interaction of the two antibodies in lymphocyte prolifer-
ation assays. The results indicate that L31 treatment is as-
sociated with significant inhibitory effects, which are paral-
leled by a marked reduction of IL -2 production (Fig. 8). It
is noteworthy that the interactions ofthe two antibodies with
the target epitopes had distinct and independent effects.
The eveptual relevance of the crossreactivitybetween HIV-1
gp120 and 02M-less class I proteins is still obscure, but two
of the findings reported herein make it, in our opinion, a
worthwhile field of further research. These are: (a) the in-
volvement ofthe M38-defined gp120 epitope in syncytia for-
mation; and (b) the involvement of 02M-less class I proteins
in regulatory mechanisms related to fundamental immuno-
cyte functions. Furthermore, it is known that lymphocyte
activation is required to make the cell susceptible to HIV-1
infection; this could depend upon the requirement for acti-
vation products such as /32m-less class I proteins.
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